1Augusto P, Javier FM, Victoria R, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer [ J ]. Gynecol Oncol 2007,105:604 - 608.
2du Bois A, Reuss A, Harter P, et al. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospect ely randomized phase Ⅲ multicenter trials[ J ]. J Clin Oncol, 2010,28(10) :1733 - 1739.
3Timmers PJ, Zwinderman AH, Coens C, et al. Understanding the problem of inadequately staging early ovarian cancer[J]. Eur J Cancer,2010, 46(5) :880 -884.
4Zanetta G, Rota S, Chiari S, et al. The accuracy of staging: an important prognostic determinator in stage l ovarian carcinoma[J]. Annals of Oncology, 1998,9 : 1097 - 1101.
5Heintz A, Odicino F, Maisnneuve P, et al. Carcinoma of the ovary 25^th annual report on the results of treatment of gynecological cancer [J]. Int J Gynecol Obstet, 2003,83( 1 ) :135 - 166.
6Edgar P, Hans-Joachim L, Gavin S, et al. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system [ J ]. European Journal of Obstetrics & Gynecology and Reproducte Biology ,2009,143 ( 1 ) :69 - 74.
7Onda T, Yoshikawa H, Yasugi T, et al. Patients with ovarian carcinoma upstaged to stage Ⅲ after systematic lymphadenectomy have similar survival to stage Ⅰ/Ⅱ patients and superior survival to other stage m patients [ J ]. Cancer, 1998,83 : 1555 - 1560.
8Myong CL, Sokbom K, Kyung SL, et al. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer[ J ]. Gynecol Oncol,2009,112 ( 1 ) : 28 - 34.
9Aletti G, Dowdy S, Podratz K, et al. Analysis of factors impacting operability in stage Ⅳ ovarian cancer: rationale use of a triage system [J]. Gynecol Oncol,2007,105(1) :84 -89.
同被引文献90
1丰有吉,沈铿主编.妇产科学[M].2版.北京:人民卫生出版社,2011:214.215.
2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
3Ovarian cancer,five-year stage-specific relative survival rates(2004-2008)[J].J Natl Cancer Inst,2011,103(17):1287.
4Von Georgi R,Franke FE,Munstedt K.Influence of surgery and postoperative therapy and tumor characteristics on patient prognosis in advanced ovarian carcinomas[J].Eur J Obstet Gynecol Reprod Biol,2003,111(2):189-196.
5Tentes AA,Mirelis CG,Markakidis SK,et al.Long-term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures[J].Int J Gynecol Cancer,2006,16(2):490-495.
6Chi DS,Liao JB,Leon LF,et al.Identification of prognostic factors in advanced epithelial ovarian carcinoma[J].Gynecol Oncol,2001,82(3):532-537.
7Vergote I,Trope CG,Amant F,et al.Neoadiuvant chemotherapy or primary surgery in stageⅢC orⅣovarian cancer[J].N Engl J Med,2010,363(10):943-953.
8Armstrong DK,Bundy B,Wenzel L,et al.Intraperitoneal cisplatin and paclitaxel in ovarian cancer[J].N Engl J Med,2006,354(1):34-43.
9Shih LM,Kurman RJ.Ovarian tumorigenesis:a proposed model based on morphological and molecular genetic analysis[J].Am J Pathol,2004,164(5):1511-1518.
